Paper8944334
Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.
Kurbacher CM and 7 others. Breast Cancer Res Treat, 1996. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay. Papers, record 8944334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8944334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Triphosphate | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Antineoplastic Agents | Major topic |
| Breast Neoplasms | Major topic |
| Doxorubicin | Major topic |
| Luminescent Measurements | Major topic |
| Mitoxantrone | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Drug Screening Assays, Antitumor | |
| Evaluation Studies as Topic | |
| Female | |
| Humans | |
| Kinetics | |
| Middle Aged | |
| Reagent Kits, Diagnostic |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7837388 | Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. | JAMA | 1995 | https://conductscience.org/library/papers/7837388 | PubMed |
| 2 | 1105174 | L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1105174 | PubMed |
| 3 | 7049348 | Direct cloning of human breast cancer in soft agar culture. | Cancer | 1982 | https://conductscience.org/library/papers/7049348 | PubMed |
| 4 | 8049500 | The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay. | Anticancer Drugs | 1994 | https://conductscience.org/library/papers/8049500 | PubMed |
| 5 | 3517241 | A comparison of mitoxantrone and doxorubicin in breast cancer. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/3517241 | PubMed |
| 6 | 8412158 | Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results. | J Surg Oncol | 1993 | https://conductscience.org/library/papers/8412158 | PubMed |
| 7 | 3806165 | A phase I-II study of intensive-dose adriamycin for advanced breast cancer. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/3806165 | PubMed |
| 8 | 8265101 | Growth characteristics of nonmalignant cells in the ATP cell viability assay. | Oncology | 1994 | https://conductscience.org/library/papers/8265101 | PubMed |
| 9 | 3965634 | The human tumor clonogenic assay in human breast cancer. | J Clin Oncol | 1985 | https://conductscience.org/library/papers/3965634 | PubMed |
| 10 | 7208525 | Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. | Prog Clin Biol Res | 1980 | https://conductscience.org/library/papers/7208525 | PubMed |
| 11 | 1559216 | Evolving concepts in the systemic adjuvant treatment of breast cancer. | Cancer Res | 1992 | https://conductscience.org/library/papers/1559216 | PubMed |
| 12 | 1246307 | Combination chemotherapy as an adjuvant treatment in operable breast cancer. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1246307 | PubMed |
| 13 | 7762413 | Comparison of MTT and ATP-based assays for the measurement of viable cell number. | J Biolumin Chemilumin | 1995 | https://conductscience.org/library/papers/7762413 | PubMed |
| 14 | 2421936 | Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2421936 | PubMed |
| 15 | 6347376 | Mitoxantrone (novantrone): a review of experimental and early clinical studies. | Cancer Treat Rev | 1983 | https://conductscience.org/library/papers/6347376 | PubMed |
| 16 | 3410347 | Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing. | Gynecol Oncol | 1988 | https://conductscience.org/library/papers/3410347 | PubMed |
| 17 | 3281747 | The contribution of medicine to the primary treatment of breast cancer. | Cancer Res | 1988 | https://conductscience.org/library/papers/3281747 | PubMed |
| 18 | 7877646 | Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7877646 | PubMed |
| 19 | 3610945 | Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth. | In Vitro Cell Dev Biol | 1987 | https://conductscience.org/library/papers/3610945 | PubMed |
| 20 | 7847834 | In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer. | Anticancer Res | 1994 | https://conductscience.org/library/papers/7847834 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35406568 | Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406568 | PubMed |
| 35328603 | Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328603 | PubMed |
| 31827757 | High-throughput three-dimensional spheroid tumor model using a novel stamp-like tool. | J Tissue Eng | 2019 | https://conductscience.org/library/papers/31827757 | PubMed |
| 20436702 | Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer. | J Korean Med Sci | 2010 | https://conductscience.org/library/papers/20436702 | PubMed |
| 17211474 | Role of the progesterone receptor for paclitaxel resistance in primary breast cancer. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17211474 | PubMed |
| 16026610 | Cancer cell adaptation to chemotherapy. | BMC Cancer | 2005 | https://conductscience.org/library/papers/16026610 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8944334
GET https://conductscience.org/api/papers/v1/8944334/references?page=2